title: Integrative tumor board: recently diagnosed prostate cancer.
authors.affiliation: mjschacht@aol.com
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Schacht
authors.forename: Gordon A
authors.initials: GA
authors.lastname: Saxe
authors.forename: Susan
authors.initials: S
authors.lastname: Bauer-Wu
authors.forename: Stacy
authors.initials: S
authors.lastname: Kennedy
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Monti
authors.forename: Caroline
authors.initials: C
authors.lastname: Peterson
authors.forename: Z'ev
authors.initials: Z
authors.lastname: Rosenberg
authors.forename: Keith I
authors.initials: KI
authors.lastname: Block
mesh_terms: D000368:Aged; D001707:Biopsy, Needle; D019033:Delivery of Health Care, Integrated; D005500:Follow-Up Studies; D006801:Humans; D007400:Interprofessional Relations; D008297:Male; D009367:Neoplasm Staging; D010348:Patient Care Team; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D017430:Prostate-Specific Antigen